Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Basile

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The International Journal of Biological Markers|September 2, 2017
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical settingLuca Miele, Teresa De Michele, Giuseppe Marrone, et al.
Journal of Personalized Medicine|January 21, 2023
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly EmbraceKrizia Pocino, Annunziata Stefanile, Valerio Basile, et al.
Journal of Personalized Medicine|February 25, 2023
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis PatientsChiara Pellicano, Amalia Colalillo, Giuseppina Cusano, et al.
Leukemia & Lymphoma|January 1, 2020
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL)Elena Maiolo, Eleonora Alma, Cecilia Napodano, et al.
International Journal of Molecular Sciences|July 12, 2025
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic FibrosisUmberto Basile, Valeria Carnazzo, Valerio Basile, et al.
Rheumatology (Oxford, England)|November 7, 2024
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosusValeria Carnazzo, Francesca Gulli, Valerio Basile, et al.
Immunology Letters|December 6, 2024
Early decrease of T-bet<sup>+</sup> B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patientsFrancesca La Gualana, Giulio Olivieri, Begi Petriti, et al.
Immunological Investigations|July 13, 2019
The Laboratory Role in anti-TNF Biological Therapy EraValentina Grossi, Francesca Gulli, Maria Infantino, et al.
Journal of Personalized Medicine|June 2, 2021
Salivary Biomarkers in COVID-19 Patients: Towards a Wide-Scale Test for Monitoring Disease ActivityCecilia Napodano, Cinzia Callà, Antonella Fiorita, et al.
Clinical Biochemistry|December 15, 2024
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AIValeria Carnazzo, Stefano Pignalosa, Marzia Tagliaferro, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The International Journal of Biological Markers|September 2, 2017
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical settingLuca Miele, Teresa De Michele, Giuseppe Marrone, et al.
Journal of Personalized Medicine|January 21, 2023
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly EmbraceKrizia Pocino, Annunziata Stefanile, Valerio Basile, et al.
Journal of Personalized Medicine|February 25, 2023
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis PatientsChiara Pellicano, Amalia Colalillo, Giuseppina Cusano, et al.
Leukemia & Lymphoma|January 1, 2020
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL)Elena Maiolo, Eleonora Alma, Cecilia Napodano, et al.
International Journal of Molecular Sciences|July 12, 2025
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic FibrosisUmberto Basile, Valeria Carnazzo, Valerio Basile, et al.
Rheumatology (Oxford, England)|November 7, 2024
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosusValeria Carnazzo, Francesca Gulli, Valerio Basile, et al.
Immunology Letters|December 6, 2024
Early decrease of T-bet<sup>+</sup> B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patientsFrancesca La Gualana, Giulio Olivieri, Begi Petriti, et al.
Immunological Investigations|July 13, 2019
The Laboratory Role in anti-TNF Biological Therapy EraValentina Grossi, Francesca Gulli, Maria Infantino, et al.
Journal of Personalized Medicine|June 2, 2021
Salivary Biomarkers in COVID-19 Patients: Towards a Wide-Scale Test for Monitoring Disease ActivityCecilia Napodano, Cinzia Callà, Antonella Fiorita, et al.
Clinical Biochemistry|December 15, 2024
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AIValeria Carnazzo, Stefano Pignalosa, Marzia Tagliaferro, et al.
Pageof 9